Skip to content
中文产业新闻评分64Chinese source

Argenx涨16%，FcRn抑制剂efgartigimod自身免疫性肌炎三期临床成功

Argenx涨16%：FcRn抑制剂自身免疫性肌炎三期临床成功

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.